Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-03

Clinical Trial Update: Apremilast for Alcohol Use Disorder Treatment in Women and Men [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating apremilast for treating alcohol use disorder in adults is active/not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apremilast (Otezla) (apremilast)

Snippet

Sponsor: Yale University | Conditions: Alcohol Use Disorder | Phase 1 | Status: ACTIVE_NOT_RECRUITING